More about

Renal Cell Carcinoma

News
June 21, 2022
4 min read
Save

Adjuvant everolimus nonsignificantly improved recurrence-free survival in renal cancer

CHICAGO — In renal cell carcinoma, adjuvant everolimus improved recurrence-free survival after nephrectomy but narrowly missed the benchmark for statistical significance, according to final results from the phase 3 EVEREST study.

News
May 12, 2022
2 min watch
Save

VIDEO: ‘Educating nurses’ key for keeping patients with renal cell carcinoma on therapies

VIDEO: ‘Educating nurses’ key for keeping patients with renal cell carcinoma on therapies

In this video Nancy Moldawer, RN, MSN, discussed strategies for educating nurses to keep patients with renal cell carcinoma on appropriate therapies, which were explored at ONS Congress 2022.

News
May 12, 2022
3 min watch
Save

VIDEO: "Nurses need to be comfortable" managing kidney cancer immunotherapy side effects

VIDEO: "Nurses need to be comfortable" managing kidney cancer immunotherapy side effects

In this video, Nancy Moldawer, RN, MSN, discussed new treatments in kidney cancer and how to apply nursing strategies to best meet the needs of patients with renal cell carcinoma.

News
April 20, 2022
3 min read
Save

Bispecific antibody shows durable benefit in advanced solid tumors

Bispecific antibody shows durable benefit in advanced solid tumors

A novel PD-1/CTLA-4 bispecific checkpoint inhibitor demonstrated antitumor activity and tolerability among patients with advanced solid tumors, according to study results.

News
April 14, 2022
2 min read
Save

Non-aspirin NSAID use may be associated with fatal renal cell carcinoma

Non-aspirin NSAID use may be associated with fatal renal cell carcinoma

Current and extended durations of non-aspirin use appeared associated with an increased risk for fatal renal cell carcinoma, according to study results.

News
April 06, 2022
1 min watch
Save

VIDEO: Ongoing trial on use of radiotherapy with ipilimumab, nivolumab in metastatic RCC

VIDEO: Ongoing trial on use of radiotherapy with ipilimumab, nivolumab in metastatic RCC

Mark W. Ball, MD, spoke with Healio about an ongoing phase 2 study assessing the use of cytoreductive stereotactic hypofractionated radiotherapy along with ipilimumab and nivolumab in patients with metastatic renal cell carcinoma.

News
April 06, 2022
1 min watch
Save

VIDEO: Study investigates using probiotic agent with standard renal cell carcinoma therapy

VIDEO: Study investigates using probiotic agent with standard renal cell carcinoma therapy

In this video, Sumanta K. Pal, MD, discusses updates from a clinical trial on the use of nivolumab/ipilimumab with and without a probiotic agent in patients with metastatic renal cell carcinoma.

News
April 04, 2022
1 min watch
Save

VIDEO: KEYNOTE-564 'critical trial' in kidney cancer

VIDEO: KEYNOTE-564 'critical trial' in kidney cancer

Sumanta K. Pal, MD, co-director of Kidney Cancer Program at City of Hope, and a HemOnc Today Editorial Board Member, spoke with Healio about studies on renal cell carcinoma presented at the 2022 ASCO Genitourinary Cancers Symposium.

News
April 04, 2022
1 min watch
Save

VIDEO: Study assessing cytoreductive nephrectomy in the 'immune checkpoint era'

VIDEO: Study assessing cytoreductive nephrectomy in the 'immune checkpoint era'

In this video, Mark W. Ball, MD, discusses the ongoing SWOG S1931 study assessing the use of immune checkpoint inhibitors with or without cytoreductive nephrectomy in patients with renal cell carcinoma.

News
March 15, 2022
1 min watch
Save

VIDEO: Adjuvant pembrolizumab may be ‘game changer’ in some patients with RCC

VIDEO: Adjuvant pembrolizumab may be ‘game changer’ in some patients with RCC

In this video, Mark W. Ball, MD, discusses updates from the KEYNOTE-564 study on the use of adjuvant pembrolizumab in certain patients with renal cell carcinoma presented at the 2022 ASCO Genitourinary Cancers Symposium.

View more